文献速递类风湿关节炎

类风湿关节炎患者肌少症患病率与危险因素的系统评价与荟萃回归分析

The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis.
PubMed 文献 · Semin Arthritis Rheum · 2020-12-17

功能受限(Steinbrocker III/IV期)、高CRP和RF血清阳性为显著危险因素;疾病病程而非年龄、地区或诊断方法影响肌少症发生,DAS28和HAQ为预测模型。

要点

  • 类风湿关节炎患者肌少症合并患病率高达31%。
  • 功能受限、高CRP和RF阳性是显著危险因素。
  • DAS28和HAQ可预测肌少症发生,应提高警惕早期筛查。

核心结论

  • 类风湿关节炎患者肌少症患病率较高,应提高临床警惕以促进早期发现。

主要发现

  • 排除离群值后肌少症合并患病率为31%。
  • 功能受限(Steinbrocker III/IV期)、高CRP和RF血清阳性为显著危险因素。
  • 基于疾病病程的荟萃回归发现DAS28和HAQ为预测模型。
  • 研究地区或诊断方法未显著影响患病率。

关键数值与推荐

  • 肌少症合并患病率为31%(排除离群值后)。
  • 显著危险因素包括功能受限(Steinbrocker III/IV期)、高CRP和RF血清阳性。
  • DAS28和HAQ为基于疾病病程的预测模型。

临床怎么用

  • 对类风湿关节炎患者应保持高度怀疑以促进肌少症早期检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia is an ever-increasingly recognized entity in aging or chronically-ill individuals. A recent surge of researches came out on sarcopenia in rheumatoid arthritis (RA). However, the results varied widely. We tried to assess the prevalence of and associated factors with sarcopenia in patients with RA. METHODS: We searched the investigations dealing with the prevalence of and associated factors with sarcopenia in RA from PubMed, EMBASE, CENTRAL, EBSCOhost, Airiti Library, CEPS, CNKI and J-STAGE from the inception to January 11, 2020. Effects regarding prevalence and associated factors were extracted and evaluated by random-effects model. Sensitivity analysis was also performed. RESULTS: Seventeen studies containing 3,140 RA subjects were identified. After exclusion of outliers, the pooled prevalence of sarcopenia was 31%. Neither ongoing-study districts nor diagnostic modalities affected prevalence significantly. Any associated factors being mentioned in at least two publications were analyzed, yielding functional limitation (Steinbrocker stage III/IV), high CRP and RF seropositivity as the significant risk factors. Based on disease durations, we carried out meta-regression and found DAS28 and HAQ are predictive models. There was no alteration in the interpretation of results from sensitivity analysis after removal of any studies skewed in sampling distribution. CONCLUSIONS: The prevalence of sarcopenia in patients with RA is high, compared to that in general counterparts. Disease duration rather than age, residing area or diagnostic modalities influences sarcopenia development; DAS28 and HAQ predict occurrence. High index of suspicion to facilitate early detection of sarcopenia in RA patients is important.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Li TH, Chang YS, Liu CW, et al. The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis. Semin Arthritis Rheum. 2020. PMID: 33385864. doi:10.1016/j.semarthrit.2020.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。